Oral anti‐viral therapy for early <scp>COVID</scp>‐19 infection in patients with haematological malignancies: A multicentre prospective cohort
Carla Minoia(Istituto Tumori Bari), Davide Fiore Bavaro(Humanitas University), Lucia Diella(Humanitas University), Pellegrino Musto(University of Bari Aldo Moro), Valentina Totaro(University of Bari Aldo Moro), Attilio Guarini(Istituto Tumori Bari), Giacomo Loseto(Istituto Tumori Bari), Michele Camporeale(University of Bari Aldo Moro), Maria Stella De Candia(Istituto Tumori Bari), Carmen Pelligrino(University of Bari Aldo Moro), Tommasina Perrone, Crescenza Pasciolla(Istituto Tumori Bari), Annalisa Saracino(University of Bari Aldo Moro), Francesco Di Gennaro(University of Bari Aldo Moro), Immacolata Attolico(Ospedale San Carlo), Felice Clemente(Istituto Tumori Bari), Vito Spada(University of Bari Aldo Moro)
Cited by 11
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665